Gsk (GSK) Change in Account Payables (2009 - 2015)

Gsk's Change in Account Payables history runs 7 years deep, the most recent figure standing at $60.7 million for Q4 2015.

• In Q4 2015, Change in Account Payables fell 57.9% year-over-year to $60.7 million; the TTM figure through Dec 2015 stood at $691.5 million (down 47.83% YoY), while the FY2018 annual figure was $175.0 million, up 1134.66% from the prior year.
• Change in Account Payables for Q4 2015 stood at $60.7 million, down from $144.2 million in the prior quarter.
• The five-year high for Change in Account Payables was $694.6 million in Q4 2011, with the low at $60.7 million in Q4 2015.
• The 5-year median for Change in Account Payables is $202.4 million (2013), against an average of $277.2 million.
• The sharpest annual moves came in 2011 and 2012: Change in Account Payables surged 185.5% in 2011, then slumped 59.08% in 2012.
• Gsk's Change in Account Payables stood at $694.6 million in 2011, then plunged by 59.08% to $284.2 million in 2012, then retreated by 28.8% to $202.4 million in 2013, then declined by 28.76% to $144.2 million in 2014, then tumbled by 57.9% to $60.7 million in 2015.
• Business Quant data shows GSK's Change in Account Payables at $60.7 million in Q4 2015, $144.2 million in Q4 2014, and $202.4 million in Q4 2013.